Rs861539

18067C>T possibly related to non-Hodgkin lymphoma

rs2040639-AG, contribute to oral cancer risk.

pseudo-haplotype with AG-CC genotypes in
 * 2.45x risk rs2040639-rs861539
 * 5.03x risk rs2040639-rs861539-rs2075685
 * 10.10x risk rs2040639-rs861539-rs2075685-rs1799782

rs4880(C;T) prostate cancer patients being treated by radiation therapy are more likely (8% compared to 0%, p=0.02) to exhibit a significant increase in grade 2 late rectal bleeding after irradiation than (C;C) or (T;T) patients, based on a study of 135 patients. The odds for this are worse if the patient also has the rs861539(C;T) genotype (14% vs 1%, p=0.002).